<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
MDGL
Madrigal Pharmaceuticals
$
()


  • Madrigal: Rezdiffra available in the U.S. for noncirrhotic NASH

    4/9/2024 - 08:09am
  • Madrigal Pharmaceuticals price target raised by $80 at Evercore ISI, here's why

    3/20/2024 - 08:13am
  • Madrigal Pharmaceuticals 750K share Spot Secondary priced at $260.00

    3/19/2024 - 05:58am
  • Madrigal Pharmaceuticals announces $500M common stock offering

    3/18/2024 - 16:05pm
  • Biotech Alert: Searches spiking for these stocks today

    3/18/2024 - 11:03am
  • What You Missed On Wall Street On Friday

    3/15/2024 - 16:31pm
  • What You Missed On Wall Street This Morning

    3/15/2024 - 12:02pm
  • BofA says 89bio should trade with strength after 'win for entire MASH space'

    3/15/2024 - 10:26am
  • DoorDash upgraded, GM initiated: Wall Street's top analyst calls

    3/15/2024 - 09:41am
  • Unusually active option classes on open March 15th

    3/15/2024 - 09:40am
  • Madrigal Pharmaceuticals price target raised by $73 at UBS, here's why

    3/15/2024 - 08:13am
  • Madrigal Pharmaceuticals price target raised by $55 at Oppenheimer, here's why

    3/15/2024 - 07:51am
  • Madrigal Pharmaceuticals price target raised by $41 at TD Cowen, here's why

    3/15/2024 - 07:30am
  • Approval of Madrigal's Rezdiffra positive for Viking and MASH space, says Stifel

    3/15/2024 - 07:17am
  • Madrigal Pharmaceuticals price target raised by $39 at Canaccord, here's why

    3/15/2024 - 07:17am
dynamic_feed Breaking News